(HealthDay)—Polymer-based zotarolimus-eluting stents are noninferior to polymer-free drug-coated stents among patients at high bleeding risk undergoing percutaneous coronary intervention (PCI), according to a study published online Feb. 12 in the New England Journal of Medicine. Stephan Windecker, M.D., from Bern University Hospital in Switzerland, and colleagues conducted a randomized, single-blind trial to compare polymer-based zotarolimus-eluting […]